Company Filing History:
Years Active: 2008
Title: Osamu Igarashi: Innovator in Lipoprotein Regulation
Introduction
Osamu Igarashi is a notable inventor based in Hitachi, Japan. He has made significant contributions to the field of health and nutrition through his innovative inventions. His work primarily focuses on the regulation of serum remnant-like lipoprotein concentrations, which has implications for dietary and pharmaceutical applications.
Latest Patents
Igarashi holds a patent for a serum remnant-like lipoprotein concentration regulator. This invention discloses serum remnant-like lipoprotein concentration regulators containing triglycerides of medium-chain fatty acids. Notably, 90% or more by weight of the fatty acids in these medium-chain triglycerides are saturated fatty acids with 8 and 10 carbon atoms. The weight ratio between the saturated fatty acids having 8 carbon atoms and those having 10 carbon atoms ranges from 60/40 to 85/15. Furthermore, the proportion of the saturated fatty acids with 8 carbon atoms in all the fatty acids bonding to the second position of the triglyceride is between 60 to 85% by weight. This invention also includes foods and pharmaceutical compositions designed to control the concentration of serum remnant-like lipoproteins, which can be used easily without concerns about side effects or restrictive diets.
Career Highlights
Osamu Igarashi is associated with the Nisshin Oillio Group, Ltd., where he continues to develop innovative solutions in the field of nutrition and health. His work has garnered attention for its potential to improve dietary practices and health outcomes.
Collaborations
Igarashi has collaborated with notable colleagues, including Hideaki Maki and Michio Kasai, contributing to advancements in their shared field of expertise.
Conclusion
Osamu Igarashi's contributions to the regulation of serum remnant-like lipoproteins highlight his innovative spirit and dedication to improving health through science. His work continues to influence the fields of nutrition and pharmaceuticals, showcasing the importance of innovation in addressing health challenges.